ease-modifying treatment for Alzheimer’s dis-
ease. 
‘‘(D) Innovations, including technological 
or telemedicine, to improve care of individuals 
with Alzheimer’s disease or dementia and to 
ease the burden of caregiving for such individ-
uals, including cost burdens. 
‘‘(E) Breakthroughs to overcome a signifi-
cant scientific barrier to understanding the pa-
thology of Alzheimer’s disease. 
‘‘(F) Other Alzheimer’s disease and de-
mentia needs, as appropriate and as determined 
by the Advisory Council described in subsection 
(c). 
‘‘(G) Other areas, as the Director of NIH 
determines appropriate. 
‘‘(2) PUBLICATION.—The Director of NIH shall 
publish each competition that is offered in the Fed-
eral Register, including the specific award amounts 
offered, applicable deadlines, and other eligibility cri-
teria. 
‘‘(3) ELIGIBILITY.—To be eligible to win a 
prize under this section, an individual or private or-
ganization— 
VerDate Sep 11 2014 
03:07 May 03, 2016
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5073.IH
H5073
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(A) shall have registered to participate in 
the competition under any rules promulgated by 
the Director of NIH under paragraph (2); 
‘‘(B) shall have complied with all the re-
quirements under this section; 
‘‘(C) in the case of a private organization, 
shall be incorporated in and maintain a primary 
place of business in the United States, and in 
the case of an individual, whether participating 
singly or in a group, shall be a citizen or per-
manent resident of the United States, unless 
the Director of NIH waives such requirement 
with respect to an organization or individual; 
and 
‘‘(D) may not be a Federal entity or Fed-
eral employee acting within the scope of their 
employment. 
‘‘(c) ADVISORY COUNCIL.—Not later than 1 year 
after the date of enactment of the EUREKA Act, the Di-
rector of NIH shall convene an Advisory Council of non-
governmental experts in Alzheimer’s disease and dementia 
to devise development of EUREKA prize competitions 
under subsection (b). The council shall be comprised of 
8 members, including— 
VerDate Sep 11 2014 
03:07 May 03, 2016
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5073.IH
H5073
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(1) 2 experts from private organizations with 
expertise in managing multi-faceted prize competi-
tions; 
‘‘(2) 2 experts in Alzheimer’s disease and de-
mentia biomedical research; 
‘‘(3) 2 experts in Alzheimer’s disease and de-
mentia therapy development, including individuals 
with expertise in designing and executing human 
clinical trials; and 
‘‘(4) 2 individuals from the caregiver or patient 
advocacy community. 
‘‘(d) EVALUATION OF SUBMISSIONS.—The Director 
of NIH, in consultation with the Advisory Council, shall 
appoint a panel of judges, from within or outside the Na-
tional Institutes of Health, including from the private sec-
tor, to review and evaluate all submissions for EUREKA 
competitions. The judging panel shall forward rec-
ommendations to the Director of NIH and the Advisory 
Council. The Director of NIH shall evaluate all submis-
sions recommended by the judging panel and select sub-
missions for which the prize shall be awarded. In reviewing 
submissions and selecting awardees, the Director of NIH 
may seek technical assistance and expertise from other 
Federal agencies or external sources, as appropriate. 
VerDate Sep 11 2014 
03:07 May 03, 2016
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5073.IH
H5073
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(e) ADMINISTERING THE COMPETITIONS.—The Di-
rector of NIH may enter into an agreement with a private 
organization to administer prize competitions, subject to 
the provisions of this section. 
‘‘(f) APPLICABILITY OF OTHER PROVISIONS.—Sub-
sections (e), (h), (i), and (j) of section 24 of the Stevenson- 
Wydler Technology Innovation Act of 1980 shall apply to 
this section. In applying such subsection (h) to this sec-
tion, the reference to subsection (g) shall be deemed to 
be a reference to subsection (b) of this section. Paragraphs 
(2) and (3) of subsection (k) of section 24 of the Steven-
son-Wydler Technology Innovation Act of 1980 shall apply 
to the appointment and functioning of the panel of judges 
described in subsection (d). 
‘‘(g) EXEMPTION FROM FACA.—The Federal Advi-
sory Committee Act (5 U.S.C. App.) shall not apply to 
the advisory council established under subsection (c) or 
the judging panel appointed under subsection (d). 
‘‘(h) PRIVATE ORGANIZATIONS.—In this section, the 
term ‘private organizations’ means nongovernmental enti-
ties, including nonprofit and for-profit entities. 
‘‘(i) FUNDING.— 
‘‘(1) IN GENERAL.—Support for a prize com-
petition under this section, including financial sup-
port for the design and administration of a prize 
VerDate Sep 11 2014 
03:07 May 03, 2016
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5073.IH
H5073
emcdonald on DSK67QTVN1PROD with BILLS
competition or monetary contributions or gifts of 
property for a prize purse, may consist of Federal 
appropriated funds, funds provided by private orga-
nizations, and individuals. The Director of NIH may 
solicit and accept funds from other Federal agencies, 
from private organizations, and individuals to sup-
port such prize competitions. The Director of NIH 
may not give any special consideration to any indi-
vidual or private organization in return for a dona-
tion. 
‘‘(2) AUTHORIZATION
OF
APPROPRIATIONS.— 
To carry out this section, there are authorized to be 
appropriated not more than $10,000,000, for each 
of fiscal years 2017 through 2021. Any funds appro-
priated under this paragraph shall remain available 
until September 30, 2025. 
‘‘(3) CLARIFICATION.—Any funds made avail-
able through this section shall supplement, not sup-
plant, other funding made available for research on 
Alzheimer’s disease and related dementia.’’. 
Æ 
VerDate Sep 11 2014 
03:07 May 03, 2016
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H5073.IH
H5073
emcdonald on DSK67QTVN1PROD with BILLS